1. Home
  2. TBBK vs LMAT Comparison

TBBK vs LMAT Comparison

Compare TBBK & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TBBK

The Bancorp Inc

HOLD

Current Price

$50.58

Market Cap

3.0B

Sector

Finance

ML Signal

HOLD

Logo LeMaitre Vascular Inc.

LMAT

LeMaitre Vascular Inc.

HOLD

Current Price

$81.59

Market Cap

2.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBBK
LMAT
Founded
1999
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.1B
IPO Year
2005
2006

Fundamental Metrics

Financial Performance
Metric
TBBK
LMAT
Price
$50.58
$81.59
Analyst Decision
Buy
Buy
Analyst Count
3
5
Target Price
$69.00
★ $105.80
AVG Volume (30 Days)
★ 565.3K
205.7K
Earning Date
04-23-2026
05-05-2026
Dividend Yield
N/A
★ 0.93%
EPS Growth
14.69
★ 30.57
EPS
★ 2.86
1.42
Revenue
$141,147,000.00
★ $249,602,000.00
Revenue This Year
N/A
$14.21
Revenue Next Year
$8.16
$8.88
P/E Ratio
★ $17.48
$56.92
Revenue Growth
★ 20.85
13.53
52 Week Low
$48.41
$78.22
52 Week High
$81.65
$118.01

Technical Indicators

Market Signals
Indicator
TBBK
LMAT
Relative Strength Index (RSI) 28.36 49.71
Support Level N/A $78.65
Resistance Level $56.38 $82.45
Average True Range (ATR) 1.62 1.61
MACD -0.12 0.62
Stochastic Oscillator 13.03 95.63

Price Performance

Historical Comparison
TBBK
LMAT

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, Credit Solutions (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Credit Solutions includes REBL (real estate bridge lending), comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.

Share on Social Networks: